{
    "clinical_study": {
        "@rank": "8120", 
        "arm_group": {
            "arm_group_label": "Nasal ganglion block for TN", 
            "arm_group_type": "Other", 
            "description": "Sphenopalatine ganglion block using the Tx360\u2122 device"
        }, 
        "brief_summary": {
            "textblock": "The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily\n      function and reduces quality of life. The sphenopalatine ganglion, located in the posterior\n      part of the middle nasal turbinate, is involved in the pain associated to TN, by blocking\n      the sphenopalatine ganglion relieves patients from the symptoms. However, methods currently\n      in use to accomplish this are either cumbersome for the patient or invasive regarding the\n      puncture of structures.\n\n      The purpose of this study is to evaluate the efficacy of Tx360\u2122, a new nasal applicator\n      device, in the treatment of   TN. A local anesthetic will be delivered on the ganglion area.\n      We are expecting that this new device will provide at least the same pain relief as the\n      previously described approaches. However, this nasal applicator is intended to be an easy\n      and non invasive method for office use."
        }, 
        "brief_title": "A Nasal Applicator for the Treatment of Trigeminal Neuralgia", 
        "completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Trigeminal Neuralgia", 
        "condition_browse": {
            "mesh_term": [
                "Neuralgia", 
                "Trigeminal Neuralgia"
            ]
        }, 
        "detailed_description": {
            "textblock": "The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily\n      function and reduces quality of life. Pain severity correlates with reduced measures of\n      daily functioning, and overall health status.\n\n      The sphenopalatine ganglion, located in the posterior part of the middle nasal turbinate, is\n      involved in the pain associated to TN, by blocking the sphenopalatine ganglion relieves\n      patients from the symptoms. However, methods currently in use to accomplish this are either\n      cumbersome for the patient or invasive regarding the puncture of structures.\n\n      The purpose of this study is to evaluate the efficacy of Tx360\u2122, a new nasal applicator\n      device, in the treatment of   TN. The Tx360\u2122 is a single use nasal applicator that can reach\n      the sphenopalatine ganglion area. It is designed to dispense medications through a flexible\n      canula.\n\n      The patients with TN will receive a 0.5 mL spray of local anesthetic  on the ganglion area,\n      and measure the change in pain intensity and quality of life.\n\n      We are expecting that this new device will provide at least the same pain relief as the\n      previously described approaches. However, this nasal applicator is intended to be an easy\n      and non invasive method for office use."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18- 80 years old\n\n          -  Trigeminal Neuralgia\n\n        Exclusion Criteria:\n\n          -  Nasal septal deformity such as: cleft lip and palate, choanal atresia\n\n          -  Septal perforation\n\n          -  Recent nasal/midface trauma (< 3 months)\n\n          -  Bleeding disorder such as Von Willebrand's disease or hemophilia\n\n          -  Severe respiratory distress\n\n          -  Neoplasm such as the following: Angiofibroma, sinus Tumors, Granuloma\n\n          -  Congestion has been present more than 10 days, fever (define as\n             temperature\u2265 100.4 F)\n\n          -  Current cocaine user\n\n          -  Skin around and inside the nasal passage is dry, cracked, oozing, or bleeding\n\n          -  Allergy to marcaine\n\n          -  Pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01761604", 
            "org_study_id": "Advocate-IRB-5241"
        }, 
        "intervention": {
            "arm_group_label": "Nasal ganglion block for TN", 
            "intervention_name": "Nasal ganglion block for TN", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "January 3, 2013", 
        "location": {
            "contact": {
                "email": "aimmc.anesthesia.research@gmail.com", 
                "last_name": "N. Nick Knezevic, M.D., Ph.D.", 
                "phone": "773-296-7927"
            }, 
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60657"
                }, 
                "name": "Chicago Anesthesia Pain Specialists"
            }, 
            "investigator": {
                "last_name": "Kenneth D Candido, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Use of Tx360\u2122 Nasal Applicator for Sphenopalatine Ganglion Block in the Treatment of Trigeminal Neuralgia", 
        "other_outcome": {
            "description": "Before procedure, baseline. And after procedure day 1, 7, 14, 21, and 28.", 
            "measure": "Modified Brief Pain inventory (short form)", 
            "safety_issue": "No", 
            "time_frame": "Before procedure and after procedure"
        }, 
        "overall_contact": {
            "email": "aimmc.anesthesia.research@gmail.com", 
            "last_name": "N. Nick Knezevic, M.D., Ph. D.", 
            "phone": "773-296-7927"
        }, 
        "overall_official": {
            "affiliation": "Chicago Anesthesia Pain Specialists", 
            "last_name": "Kenneth D Candido, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in pain intensity before procedure, baseline. And after procedure 15 minutes, 30 minutes, day 1, 7, 14, 21, and 28.", 
            "measure": "Pain intensity numeric rating scale", 
            "safety_issue": "No", 
            "time_frame": "Before procedure and after procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01761604"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Chicago Anesthesia Pain Specialists", 
            "investigator_full_name": "Kenneth D Candido", 
            "investigator_title": "Chairman of the Anesthesia Department at Advocate Illinois Masonic Medical Center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Before procedure, baseline. And after procedure 30 minutes, day 1, 7, 14, 21, and 28.", 
            "measure": "Patient's global impression of change", 
            "safety_issue": "No", 
            "time_frame": "After procedure"
        }, 
        "source": "Chicago Anesthesia Pain Specialists", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chicago Anesthesia Pain Specialists", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2013"
    }
}